Algernon Health Inc. is a listed company. Filings by its managers are published through SEDI. In the past year (18 October 2025 to 18 October 2026), 2 filings came from 1 insider.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
No insider has bought Algernon Health Inc. shares on the open market in the past twelve months.
Compared with its exchange (2,144 companies, median 12 filings), a count of 2 filings is below the norm.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
2 of 2 declarations
Algernon Health Inc. is a company focused on developing innovative treatments for serious diseases. It is listed on the XTSE market.